Objective Cranial radiotherapy (CRT) was until recently, important for achieving long-term survival in acute lymphoblastic leukaemia (ALL). Because survival rates have markedly improved, the long-term complications, such as GH deficiency (GHD) and neuropsychological impairment, has become increasingly important.
Introduction
Acute lymphoblastic leukaemia (ALL) accounts for one quarter of all childhood cancers and is the most common childhood malignancy. 1 To prevent central nervous system relapses, prophylactic cranial radiotherapy (CRT) together with multiagent therapy including intrathecal methotrexate (MTX) was considered important for achieving long-term survival of patients with childhood onset (CO)
ALL and survival has improved greatly to approximately 80%. 1 However, CRT at doses of 18 to 24 Gy, 2, 3 with intrathecal MTX 4 resulted in intellectual impairment. 3 More substantial declines in IQ have been associated with young age at CRT [5] [6] [7] [8] [9] and girls seem to be more vulnerable. 2, 7, 10 A decline in intellectual functioning has been shown 4-8.5 years after treatment with 18-24 Gy of CRT, 11 but information on longer follow-up is missing.
Another problem for these patients is hypothalamic-pituitary hormone insufficiency which is a well recognized sequel of external CRT for childhood brain cancer. 12 A significant occurrence of GHD has been shown in adults treated in childhood with lower doses of CRT, e.g. in CO ALL. 13, 14 GHD is usually the first and often the only established endocrine sequel of CRT. 15 Patients with GHD due to primary hypothalamic-pituitary disease are known to experience reduced quality of life 16, 17 and neuropsychological dysfunction. [17] [18] [19] Previous studies after CO ALL have assessed neuropsychological functioning in childhood or during adolescence but not in adulthood. Neuropsychological dysfunction has also not previously been related to a possible decline in GH secretion in this patient group. Quality of life assessed by telephone interviews in adults with CO ALL showed a greater negative mood, 20 poorer interpersonal functioning and problems in coping with relationships and friendships, compared to controls. 21 However, there is no information on this patient group with respect to their self-rated quality of life or social functioning.
One aim of the present study was to assess neuropsychological functioning and the accomplished educational level in 44 adults who had survived CO ALL and who were at least 18 years old at the time of study. A further aim was to investigate their self-rated quality of life, social interactions and social networks. Comparison was made with matched controls from the general population. Furthermore, a subset of former ALL patients with GHD were evaluated for neuropsychological functioning after one year of GH treatment.
Subjects and Methods

Patients
Adult patients treated for CO ALL with chemotherapy and CRT during at the Children's Hospital, Lund, were invited to participate. Patient characteristics, including previous treatments, and the cardiovascular risk factors have been described in a previous report. 14 Briefly, the study included 44 patients (23 male, 21 female) with a median age of 24.8 years (range 19.8-31.3), who had been diagnosed with ALL at a median age of 4 years (1-17 years). The patients had been treated with CRT, at a target dose of [24] [25] [26] [27] [28] [29] [30] , at a median of 20 years previously (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) , and had been off chemotherapy for a median of 16.7 years (6.3-23.9). Gy) and 12 boys received radiation to the testes. Five patients had been treated for relapse, one patient for more than one relapse, and one patient had been treated with high dose chemotherapy with autologous stem cell rescue.
GH treatment in childhood had been given to 4 patients, though not for at least 5 years. One female had primary amenorrhea and 5 were using estrogen contraceptives. Thus, all but one female had isolated GHD or GH insufficiency.
Testosterone was appropriately administered to 10 of the 12 males who had received radiation to the testis; one male had not been properly irradiated due to an undescended testis and had normal testosterone levels, while the other was not sufficiently substituted. Thus, all but 11 males, who were given sufficient testosterone substitution, had isolated GHD or GH insufficiency. There was also one male patient receiving thyroxine replacement. No significant differences were recorded in the serum levels of TSH, FT4, FT3, testosterone, estradiol, and cortisol between patients and controls (data presented elsewhere 14 )
.
Control subjects
The intention was to select one control subject for each patient enrolled in the study, and method of selection was the same as that described previously for the investigation of cardiovascular status. 14 Potential control subjects, matched for age, gender and residence (rural/non rural), were randomly selected from a computerized register (Southern Swedish Medical Region) of the population in the local area of the patients. Potential controls were contacted by telephone, were then also matched for smoking habits and, for each patient, the first eligible control that agreed to participate in the study was chosen.
Study design
The Ethic's Committee of Lund University approved the study protocol and all subjects gave written informed consent. For each patient and control, all investigations were performed on a single day, except for the GH stimulation tests.
All patients and controls underwent a GHRH-arginine test. 25 After an interval of at least one month an additional insulin tolerance test (ITT) was performed in each patient; however, the ITT results could not be used for five patients: one due to technical problems and four due to failure to achieve acceptably low blood glucose levels in spite of a repetition of the test. 26 The ITT was performed after an overnight fast with 0. 31 The format is thus disease-oriented and consists of 25 statements to which a "yes" or "no" response is requested. The score range for the AGHDA is 0-25; a score of 25 represents the greatest morbidity.
The Interview Schedule for Social Interaction (ISSI) is a self-reported questionnaire about the quantity and quality of social support. 32, 33 It consisted of 33 items combined into four scales measuring availability and adequacy of attachment, as well as availability and adequacy of social integration.
The 16-item Social Network questionnaire reflected the structural level, i.e. the availability of social support but not the subjective experience of its adequacy. [34] [35] [36] Availability of instrumental support reflected the access to practical services and material resources, and availability of emotional support reflected the opportunity for care, encouragement of personal value, and feelings of confidence and trust.
Social anchorage reflected to what degree the individual belonged to formal and informal groups in the social network, and the degree of feeling of membership in these groups. Social participation indicated how actively the individual took part in activities of formal and informal groups in society.
Neuropsychological tests
All subjects were examined individually with a battery of neuropsychological tests, administered by the same psychologist. All manual scoring was cross-checked by a second psychologist. For every participant the tests were given in the same fixed sequence. The selection of tests was governed by a demonstrated high sensitivity for subtle brain dysfunction, 37 while covering a wide array of functional domains. To supplement the basic analysis of raw scores from the neuropsychological tests, each subject's mean z-score across all nine tests was calculated to provide a summary measure of performance. were summarized in a total mean z-score for each patient.
School education and marital -social status
School education was rated at three levels i.e. nine years of elementary school, secondary school or studies at university level. All forms of education after secondary school was classified as studies at university level. Marital and social status was investigated with a questionnaire.
Statistical analysis
Data were analyzed with SPSS, version 11.5. The level of statistical significance was set at P<0.05. The matched pairs of patients and controls were compared with the Wilcoxon´s signed rank test, which was also used to study the neuropsychological scores at one year follow-up. For this analysis, each patient's score on each test variable in the first examination was subtracted from the followup score, and the Wilcoxon´s signed rank test was used to compare the difference between scores for the matched pairs. The independent effects of (i) years since CRT treatment, (ii) age at CRT treatment, (iii) peak GH response during the GHRH-arginine test, and (iv) dose of CRT, on neuropsychological performance among patients (total mean z-score), were evaluated with linear multiple regression based on ranked data. Mann-Whitney's U-test was used for comparisons between subsets of patients. Differences in educational level and social status were tested by the McNemar's test for correlated proportions.
Results
Quality of life measures, social interaction and social network
No statistically significant group differences were observed across any of the nine SCL-90 subscales, nor for the overall distress measure GSI (Table 1) 
Educational, social-and marital status
A significantly lower level of education was recorded among patients, with 23% reaching university level compared to 55% in the control group (P=0.01). Within the patient group there was no obvious association between age at treatment and level of school education (data not shown).
Four of the patients and 7 control subjects were married, which was not significantly different (P=0.45). However, significantly more patients than controls (28 patients vs 17 controls; P=0.019) were living alone or together with parents.
Neuropsychological tests
Compared to controls, the former ALL patients had a generally lower performance in neuropsychological tests, reaching statistical significance in 14 of the 20 test variables ( Table 2 given CRT before the age of six had significantly lower mean z-score across all tests (z = -1.18; n=27) than those treated at a higher age (z = -0.66; P=0.019; n=17).
A wider variation in performance was observed within the early treatment group, with a subset of patients having particularly low mean z-scores ( Figure 1 ). While 10 of the 27 patients treated with CRT before the age of six had a mean z-score in the range -3.4 to -1.5, none of the 17 patients treated at a higher age had a mean zscore below -1.3. The strength of this study is that it is the longest follow up (median 17 years) of a homogenous group of adult survivors of CO ALL, treated with cranial irradiation and chemotherapy, including intrathecal MXT. Another, strength is the appropriate control group, randomly recruited from the general population and matched for age, gender, smoking habits and residence. Because a similar percentage of potential controls (7%) as ALL patients (5%) declined participation due to health reasons, we consider it unlikely that the recruitment of the control group resulted in any important selection bias. We were not able to include a control group of non-irradiated ALL patients, as no such group was available that were comparable with respect to risk group classification, calendar-year of diagnosis, length of follow up and chemotherapy schedule.
The effect of one year of GH treatment on neuropsychological functioning and on serum IGF-I levels
The tests used in this study to evaluate neuropsychological performance are well established and validated. 17, 37, 39 Further, to eliminate possible effects of an examiner-specific variation, the neuropsychological examination was administered by the same psychologist both at baseline and at one year follow-up.
Previous studies of psychosocial sequelae in adults who survived CO ALL, have shown greater negative mood disturbances with more symptoms of depression, confusion, tension and anger as compared to siblings. 20 Also poorer self image and greater psychological distress have been shown in patients receiving CRT compared to those treated with intrathecal MTX without CRT. 45 This is in contrast to the present study where no difference in any of the SCL-90 subscales could be detected. In addition, when using the disease specific quality of life questionnaire for adult GHD AGHDA, did not change these results. A possible explanation may be that these patients had developed coping strategies and adapted to their situation.
This mechanism has been suggested for patients with CO GHD, who reported fewer disturbances in quality of life than those with adult onset GHD. 46, 47 In the present study, 91% of the ALL patients were GHD and the rest were GH insufficient, and the GH impairment had probably existed for some time. 48 It seems however, that there is a marked mismatch between perceived quality of life in subjects with CO GHD and their behaviour and social and economic achievements. 49 Thus, it has been suggested that self-rating questionnaires may underestimate the true impairment of quality of life in CO GHD patients. 47, 50 In irradiated GHD adult survivors of childhood brain tumours, who were selected on the basis of self-rated poor quality of life to receive GH treatment, a marked improvement could be recorded after GH treatment. 51 These adult survivors of childhood cancer were treated with higher doses of CRT and at an older age (13 yrs) than the patients in the present study. However, no information of neuropsychological functioning was recorded in the study by Mukherjee et al., 51 In addition, another more disease specific quality of life questionnaire for GHD used in a selected cohort of patients in the transition phase from end of puberty to adulthood, have shown significant differences at baseline in parameters as selfassessed body shape and sexual behaviour.
52
In a previous study 53 it was shown that adult survivors of CO ALL reported poorer interpersonal functioning and coping for love/sex relationships and friendships, compared to controls. This is partly in contrast to the present study in which the patients reported no significant difference in the quantity and quality of social support. Again, in the study by Mackie et al., 53 , the information was based on interviews and not on self-rating questionnaires, which may have influenced the results. Circumstantial evidence that the patients in the present study may have overestimated their social interaction and support was that significantly more of them still lived alone or with their parents, compared with their age-matched controls. This is in accord with the finding of Dean et al. 54 who recorded that the percentage of patients with CO GHD who were married was 30% less than would be expected for their age. No difference in current treatment of depression was recorded between patients and controls in the present study, which is consistent with a previous study.
53
In children treated for ALL, long-term assessment of musculoskeletal and gross motor function, including strength, balance, hand grip and running speed, has shown poorer performance than in age and sex matched controls. 55 Even if no statistically significant difference was found between the groups who had received CRT and those who had not, the scores for the children who had received CRT indicated greater impairment and disability in most parameters. 55 Also fine and gross motor evaluations have shown significantly poorer functions than in age and sex matched controls. 56 In parallel, the former ALL patients in the present study showed a slower performance in the perceptual and fine motor speed test (WAIS-R Digit Symbol) compared with the controls.
Impairment of short term memory and attention has previously been reported in CO ALL treated with both 18 and 24 Gy. 7 The mechanism was suggested to be a lower strategic planning behaviour affecting memory recall. 57 This agrees with the results of the present study, showing lower scores in tests of spatial learning and verbal memory. Attentional deficits, in comparison to sibling controls, were also recorded in a group treated with 18 Gy and intrathecal MTX, 58 which is in accordance with the impairment of sustained attention recorded in the present study.
The neurocognitive impairments shown in former ALL patients, lead to a greater likelihood of being placed in special education or learning-disability programs than siblings, 5, 9 and a significantly lower number of former ALL patients enter secondary education or college. 5, 9 This is consistent with the present study where a disproportionably low number of former ALL patients reached university level. In previous studies, early age at diagnosis was the risk factor most related to low educational level. [5] [6] [7] 9 Our results did not support this, comparing subjects diagnosed up to 6 years of age with those diagnosed later. On the other hand, we observed that the mean neuropsychological test score for the patients correlated strongly with age at treatment. However, longer time since CRT treatment was not shown to have an adverse effect on neuropsychological performance in a regression model including control for age at CRT treatment. This is a novel finding that is partly in contrast to others, 11 who showed a clear reduction in intellectual function with lengthening time after 18 Gy of CRT in childhood ALL patients. However, in 80% of the children this decline appeared 4 to 8.5 years after diagnosis, indicating that extrapolation outside this range would be an over interpretation of that data.
Thus, the present study is the first to show no further decline in neuropsychological capacity in the period 8 to 27 years after CRT.
In some studies, 2, 7 but not all, 9 girls have shown more impairment of verbal IQ and of global depression of cognitive functioning after CRT and MTX 10 compared to boys. It has been speculated that global deficits might be associated with diffuse axonal injury, a neurotoxicity that might be both endocrine dependent and worsened by large doses of chemotherapy. 59 The present study, which included an equal proportion of women and men with former CO ALL, showed no gender difference in neuropsychological functioning in adulthood. The men and women in the present study were well-matched for percentage that had been treated with CRT up to age 6 years, age at diagnosis and at CRT, the target doses of CRT and risk group classification.
GH status has not been taken into account in relation to neuropsychological outcome in previous studies of former CO ALL patients. 2, 4 In the present study, treatment with GH for one year did not yield any improvement in neuropsychological test scores, compared with changes in the controls. One explanation might be that irreversible brain damage had been caused by CRT and/or chemotherapy in childhood. Moreover, the lack of GH and/or IGF-I during brain development could result in deficient neuronal and glial growth or suboptimal myelinisation, 60 which may not be reversible later in life. While development of cortical grey matter peaks at approximately four years of age, cortical white matter volume increases continuously until age 20 years 61 and even slight pathology of white matter has been associated with distinct attentional dysfunction. 62 Low levels of GH/IGF-I have been shown to parallel a reduction in attention-related brain potential from EEG traces. 63 However, contrary to this hypothesis of irreversible brain damage due to GHD, adults with CO GHD have shown improvements in cognitive function with GH treatment. 64 Further, in experimental studies peripheral infusion of IGF-I induced neurogenesis selectively in the adult rat hippocampus, a part of the brain connected with memory. 65 Another possible explanation for the lack of improvement after one year of GH is that the treatment period was too short to elicit a beneficial effect. However, Oertel et al. 66 found that GH substitution to adult onset GHD patients induced an improvement of attentional performance after only 3-6 months of GH treatment, and an improvement in cognitive function was also recorded in patients with
Sheehan's syndrome and GHD after 6 months of GH treatment. 19 In adult men with CO GHD, an improvement in memory function was recorded after one year of GH treatment. 61 Different background diagnosis, age at diagnosis and whether CRT is the cause of GHD or not may explain differing results.
In conclusion, young adults with ALL in childhood treated by CRT and chemotherapy, and with confirmed GHD or insufficiency, had impaired neuropsychological performance but no difference in self-reported quality of life compared to matched population controls. One year of GH treatment did not improve scores in neuropsychological tests, which might either reflect irreversible damage to the brain, caused by CRT per se or by irradiation-induced GHD, or that the GH-treatment period was too short in this group of patients. This study again emphasises the importance of identifying the specific deficits in these patients and providing adequate support and training programs at an early age, together with educational support later in life. The effect of treatment with GH in this patient group has to be further elucidated and we need to understand whether GH ought to be introduced at a young age to perhaps counteract the cognitive impairment sequelae. 
